Glossary | 色花堂Finance Times

Glossary

Naked Short Selling

The practice of short selling without first borrowing the security or ensuring that it can be borrowed, which is illegal in many markets.

Naked Short Selling News

Regulation
Thailand to increase brokerage violation fines

The fine penalty against naked short selling and failed margin calls will triple from 1 November

Industry
Financial Services Commission applies short selling ban in South Korea

The ban will commence from 6 November 2023 until the end of June 2024, and will prohibit the short selling of all KOSPI, KOSDAQ and KONEX listed items

Industry
South Korea tightens oversight of short selling

The Financial Services Commission (FSC) has announced a package of measures designed to tighten supervision of illegal short selling and to improve the operation of the short-selling system

Regulation
Swedish regulator fines Nordnet for intraday short selling violations

Finansinspektionen has fined online banking provider Nordnet for failing to meet to its terms of service relating to intraday short selling, including deficiencies in its risk management policies and failing in its duty of care to customers

Regulation
Malaysia鈥檚 intraday short selling ban to lift on 1 Jan

Short selling is to be reintroduced from the new year, subject to additional control measures including application of 鈥渁t-tick rule鈥�

Regulation
FSC finalises beefed-up short selling rules

The revisions are designed to tighten short selling regulations before the lifting of the short selling ban early next month

Regulation
Second GameStop hearing to focus on securities lending disclosure proposals

Witnesses from brokers, market utilities and universities are expected to call for amendments to Regulation SHO, Dodd-Frank, and Form 13F, while pitching new concepts for reporting securities lending activities

Industry
International brokers sued over naked short selling allegations

A Bermuda-based hedge fund has filed a suit in a New York court alleging that CIBC, Bank of America, UBS and TD Bank gamed the market causing shares it held in a major pharmaceutical to tumble in 2016